ETX-123

N/A

Report date: 2024/06/03 16:43:50
NME

Base Information

Drug NameETX-123
Drug Alias NameETX-123
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium voltage-gated channel subfamily KQT member 3 stimulantsVoltage-gated potassium channel subunit Kv7.2 stimulants
TargetsPotassium voltage-gated channel subfamily KQT member 3Voltage-gated potassium channel subunit Kv7.2
Therapy Area/IndicationsDepressionPainEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEliem Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEliem Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsDepressionPainEpilepsy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A